Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin versus tranexamic acid + ethamsylate for reducing intraoperative bleeding during cesarean section
PACTR202009736186159Not yet recruiting
- Sponsor
- Elgalaa Teaching Hospital
- Start
- Oct 2020
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of oxytocin, tranexamic acid and etamsylate in postpartum hemorrhage (PPH) (2 arms), sponsored by Elgalaa Teaching Hospital. Primary endpoint: amount of blood loss. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
oxytocintranexamic acidetamsylate
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202009736186159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202009736186159.